FIELD: medicine, cardiology.
SUBSTANCE: it is suggested to apply cortisol antagonists in addition to clonidine while manufacturing preparation to treat heart failure. Moreover, one should introduce cortisol antagonist or a product that includes cortisol antagonist along with the second medicinal preparation being a combined preparation to be applied either simultaneously, separately or successively. The present innovation provides decreased symptoms of heart failure at decreasing cardiac muscle's fibrosis and heart sizes due to preferable impact upon glucocorticoid receptors in patient's heart and/or kidneys.
EFFECT: higher efficiency of application.
12 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR LEFT VENTRICLE DIASTOLIC FUNCTION IMPROVEMENT | 2012 |
|
RU2627842C2 |
| METHODS OF TREATING PULMONARY HYPERTENSION | 2012 |
|
RU2599490C2 |
| METHOD FOR TREATING DOGS WITH DILATED CARDIOMYOPATHY COMPLICATED BY CONGESTIVE CARDIAC FAILURE | 2020 |
|
RU2762989C1 |
| METHOD OF TREATING PATIENTS WITH RADIATION EXUDATIVE PERICARDITIS | 2009 |
|
RU2415667C1 |
| 1,3-DIHYDROIMIDAZOLE-2-THIONE DERIVATIVES FOR USE IN TREATING PULMONARY ARTERIAL HYPERTENSION AND LUNG INJURY | 2013 |
|
RU2718055C2 |
| METHOD OF URINARY NORMALISATION IN RENAL MALFUNCTION | 2004 |
|
RU2367442C2 |
| PREPARATIONS FOR TREATMENT OF METABOLIC SYNDROME COMPRISING HUMAN GROWTH HORMONE IN COMBINATION WITH CORTISOL SYNTHESIS INHIBITOR | 1998 |
|
RU2198679C2 |
| 1,3-DIHYDROIMIDAZOLE-2-THIONE DERIVATIVES AS DOPAMINE-BETA-HYDROXYLASE INHIBITORS | 2008 |
|
RU2501796C2 |
| COMBINATION THERAPY OF PULMONARY HYPERTENSION | 2016 |
|
RU2780758C2 |
| METHOD FOR TREATING DOGS WITH MITRAL VALVE ENDOCARDIOSIS | 2020 |
|
RU2745653C1 |
